This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 1995.
Company Filing History:
Years Active: 1995
Title: S Richard Baker: Innovator in Leukotriene Antagonists
Introduction
S Richard Baker is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of leukotriene antagonists. His work focuses on compounds that can effectively address conditions characterized by excessive leukotriene release.
Latest Patents
S Richard Baker holds a patent for "Substituted phenyl phenol leukotriene antagonists." This patent describes antagonists that possess a substituted phenyl phenol or a substituted phenolic biphenyl structure, along with various derivatives. The patent details their structures, uses, and synthesis, providing valuable insights into pharmaceutical formulations aimed at treating diseases linked to the excessive release of leukotriene B.sub.4, a metabolite of arachidonic acid.
Career Highlights
Baker is associated with Eli Lilly and Company, a leading pharmaceutical firm known for its innovative research and development. His work at the company has contributed to advancements in therapeutic solutions for various medical conditions.
Collaborations
Some of his notable coworkers include Michael J Sofia and J Scott Sawyer, who have also made significant contributions to the field of pharmaceuticals.
Conclusion
S Richard Baker's innovative work in the development of leukotriene antagonists highlights his important role in advancing pharmaceutical science. His contributions continue to impact the treatment of conditions related to leukotriene release.